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Abstract
Breast milk has been shown to have multiple benefits to infant health and development. Therefore,
it is important that maternal contraceptive choices consider the effects on lactation. Women who
observe traditional Jewish law, halakha, have additional considerations in deciding the order of
preference of contraceptive methods due to religious concerns including the use of barrier and
spermicidal methods. In addition, uterine bleeding, a common side effect of hormonal methods and
IUD, can have a major impact on the quality of intimacy and marital life due to the laws of niddah.
This body of Jewish laws prohibits any physical contact from the onset of uterine bleeding until its
cessation and for an additional week. Health care professionals should understand the issues of
Jewish law involved in modern contraceptive methods in order to work in tandem with the halakha
observant woman to choose a contraceptive method that preserves the important breastfeeding
relationship with her infant and minimizes a negative impact on intimacy with her husband.
Review
Medical encouragement of breastfeeding
Breastfeeding is endorsed by major health organizations
as the optimal form of infant nutrition. When infants do
not receive breast milk, there are increased health risks for
both mother and infant. For women who do not breast-
feed, there are increased risks such as an increased risk of
breast cancer [1,2]. Research in developed and developing
countries has demonstrated that infants who are not
breastfed are at increased risk of infant mortality [3-5].
Infants who do not receive breast milk have an increased
incidence of many acute [5,6] and chronic conditions [7-
9]. To quote the recent policy statement of the American
Academy of Pediatrics, "Human milk is species-specific,
and all substitute feeding preparations differ markedly
from it, making human milk uniquely superior for infant
feeding" [10] (see p. 496). Exclusive breastfeeding is the
ideal infant nutrition; it is sufficient to support optimal
growth and development for approximately the first six
months of life. This half-year of exclusive breastfeeding
should be followed by a gradual introduction of iron-
enriched complementary solid foods with continued
breastfeeding for at least twelve months, and thereafter for
as long as mutually desired. Therefore, it is important for
all health care professionals to protect breastfeeding and
minimize barriers that may threaten the mother-infant
breastfeeding relationship.
Jewish law and its place within Judaism
The composite body of Jewish law is known as halakha. It
is a system that has evolved over at least two millennia.
Written halakhic works include the Mishna  (edited
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approximately 200 A.D.), the Talmud  (edited approxi-
mately 500 A.D.), and the works of Maimonides (written
in approximately 1250 A.D.). The Shulkhan Arukh (written
in 1564 by Rabbi Yosef Karo) is considered a binding cod-
ification of laws with discussion and development via
response, rabbinic questions and answers, continuing to
the present day. Questions that arise within or related to
Jewish law are addressed to a halakhic authority for clari-
fication of proper practice. The laws subsumed under
halakha may be divided into biblical and rabbinic origin.
Both are binding on the halakha observant Jew. However,
at times rabbinic injunctions have more room for leni-
ency, especially in extenuating circumstances. In general,
people who ascribe themselves to Orthodox Judaism view
halakha as binding. The proportion of Jews who identify
themselves as Orthodox varies with location. Even within
those who define themselves as Orthodox there is varia-
tion in the strictness of practice and the degree to which
they consult with a rabbinic authority when questions of
practice arise.
Encouragement of breastfeeding and childbearing within 
Jewish law
Breastfeeding is valued by Jewish tradition, as are health
promotional practices [11]. The Talmud discusses breast-
feeding duration in a number of contexts and in most
cases assumes a duration of 24 months (Ketuvot 60a, b)
[12]. The Shulkhan Arukh codifies a minimum of two years
(Even Haezer 143:8) and a maximum of five years (Yore
Deah 81:7) [13]. Maimonides recommends breastfeeding
in his compilation of Jewish law, the Mishneh Torah LeR-
ambam (Gerushin 11:26) [14]. There are other references
in traditional texts including discussion in the Talmud
regarding breastfeeding durations of two through five
years [15]. There is also mention of the importance of pre-
serving breastfeeding that could potentially be challenged
by subsequent pregnancy (Yevamot 12b) [12].
Jewish tradition values childbearing, as derived from the
biblical commandment and divine blessing in Genesis
(1:28 and 9:7), "be fruitful and multiply" [16]. Maimo-
nides explains that this commandment is considered ful-
filled with the births of at least one son and one daughter
and indicates a separate rabbinic injunction to continue
having children as long as one is able. (Mishneh Torah LeR-
ambam, Hilchot Ishut, chapter 15) [14]. The biblical com-
mandment to procreate is considered to be directed to
men, with women being the conduit through which this
commandment is fulfilled.
Permissibility of contraception
Despite the halakhic emphasis on childbearing, there are
times where contraception is permitted or even man-
dated. Permission for use of contraception is carefully
considered for each individual couple by a halakhic
authority. The most halakhically endorsed indication for
contraceptive use is when pregnancy poses a threat to a
woman's life related to the Jewish principle of Pikuach
Nefesh, saving a life, whereby danger to life suspends all
commandments, excluding adultery, idolatry and murder
(Shulkhan Arukh, Yore Deah 336:1) [13]. Contraception
may be considered under other situations as well, where a
woman's physical or emotional well-being is threatened
[17-19], and in the case of the breastfeeding maternal-
infant dyad, to preserve the provision of breast milk qual-
ity and quantity for the infant, as stated in the Talmud
(Yevamot 12b) [12,20]. However, there are halakhic con-
siderations and issues for both men and women that must
be taken into account in determining the method of con-
traception. Overall, it is easier to permit female contracep-
tive use rather than male contraceptive use as the nature
of the injunction not to use male contraception is biblical
and therefore considered of a higher order compared to
the rabbinic injunction regarding female contraceptive
use [17].
Talmudic discussion of female contraception
Halakhic considerations often begin with Talmudic dis-
cussion and precedents. One method of female contracep-
tion mentioned in the Talmud  is the moch, defined as
either a tampon-like device inserted into the vagina prior
to intercourse or a post-coital sponge. Some contempo-
rary halakhic authorities compare the moch  to modern
barrier methods [15] such as the diaphragm, cervical cap
and contraceptive sponge. The Talmud (Yevamot 12b) [12]
discusses use of the moch as a contraceptive method by
lactating women, although the extent and conditions of
its use are debated. These debates play a role in the con-
temporary rabbinic hesitation in permitting the use of
barrier methods [21]. Another method mentioned in the
Talmud is a contraceptive drink used to induce infertility
that may have been permitted for women with a history of
traumatic childbirth [15].
Halakhic considerations in choice of contraceptive 
method
Permanent sterilization (sirus) is prohibited based upon a
biblical prohibition (Leviticus 22:24) [16], which is con-
sidered for men of strict (biblical) origin, whereas, for
women, of less strict (rabbinic) decree, as delineated in
the halakhic work, the Shulkhan Arukh [13]. As such,
vasectomy and tubal ligation, considered permanent con-
traception, are prohibited by Jewish law. There is some
leniency for tubal ligation in special cases, especially since
this method may be reversed or circumnavigated with
assisted reproductive technology [22-24].
Another important consideration for contraceptive use is
the halakhic prohibition of purposeful emission of semen
outside the vaginal canal. Therefore, coitus interruptus isInternational Breastfeeding Journal 2007, 2:1 http://www.internationalbreastfeedingjournal.com/content/2/1/1
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forbidden (Yevamot 34b) [12]. Likewise, condom use is
forbidden since the condom impedes sperm from enter-
ing the vaginal canal. This issue has implications for
female use of barrier methods as well, as will be further
discussed. As the currently available male methods of con-
traception, condoms and vasectomy, are prohibited, the
remaining discussion is limited to female methods of con-
traception.
A critical consideration regarding female use of contracep-
tion is the propensity of the method to cause uterine
bleeding or staining. According to Jewish law, a woman is
rendered a niddah when she experiences uterine spotting
or bleeding that is not due to injury. While she is a niddah,
no physical contact is permitted between husband and
wife, thereby affecting marital intimacy. A woman who
has entered the status of niddah remains in that state until
she has completed the ritual requirements regardless of
how many days she actually bleeds. These requirements
include a minimum of twelve days that must elapse from
the onset of her niddah status and proper immersion in a
ritual bath. The twelve day minimum is divided into two
phases: (1) a five day minimum for menstruation, even if
her menses are shorter than five days; and (2) seven
"clean" days, whereby the woman verifies that bleeding
has not recurred by doing internal self examinations. Any
intermittent bleeding during this process may necessitate
restarting the count of seven days. A woman after child-
birth must also follow the laws of niddah and refrain from
physical contact with her husband until all postpartum
bleeding has stopped and the additional week of the
"clean" days has passed. Likewise, bleeding or spotting
that may accompany some contraceptive methods (and
are often considered medically insignificant) may signifi-
cantly impact the intimacy and quality of marital life for
women who observe the Jewish laws pertaining to niddah.
Since not every stain renders a woman a niddah, a woman
experiencing breakthrough bleeding should consult with
her halakhic authority. For halakhic questions regarding
the issues of family purity and to learn more about
women's health issues in Jewish law, refer to online web-
site resources (including [25] and [26]), or contact the tel-
ephone hotline 1-877-YOETZET (toll free in the United
States and Canada).
In general, when contraception is used, it should be a
method that does not involve male awareness of its use
during intercourse and should not interfere in normal sex-
ual relations. The following discussion will address the
halakhic considerations of specific contraceptive methods
for women.
Non-artificial methods of contraception
For the lactating woman, a short-term method of contra-
ception that poses no halakhic problem is that of the lac-
tational amenorrhea method (LAM). This method, as
described in the medical literature, capitalizes on the ano-
vulation associated with breastfeeding for up to six
months postpartum, assuming the woman has not
resumed menses and is exclusively or almost exclusively
breastfeeding (including breastfeeding at night). LAM has
been demonstrated to be over 98% effective in trials
worldwide [27,28]. It also has the added health benefits
for mother and infant. Halakha encourages breastfeeding
duration of at least two years, without concern for poten-
tial reduction in fecundity during lactation [29]. LAM
poses no halakhic problem and thus should be encour-
aged for breastfeeding women who are not considering
artificial methods, allowing the woman time for postpar-
tum recuperation. Practically, however, for women who
require highly effective and reliable contraception, LAM
may be insufficient. While some women experience lacta-
tional amenorrhea as long as they breastfeed, they cannot
be assured of effective prevention of pregnancy beyond
the first six months. Furthermore, the method is based on
frequency of breastfeeding, including night feeds. For
women who leave their infants and work outside the
home, the difficulties in maintaining this frequency can
increase the failure rate [27].
Natural family planning (NFM) is another non-interven-
tion method involving the measurement of physiologic
changes, including basal body temperature and cervical
mucous changes [30]. In the lactating woman, these phys-
iologic changes are often difficult to detect. Obtaining
basal temperature changes requires at least four hours of
uninterrupted sleep, which may be challenging for the
breastfeeding mother. Unlike LAM, where intercourse can
take place whenever desired by the couple, intercourse
must be avoided (or combined with a barrier method) at
the time that the woman is potentially fertile, which
requires halakhic permission. Furthermore, as the hala-
kha observant woman may not have physical contact with
her husband for at least the first twelve days of her cycle,
removing additional days until after the fertile period has
passed increases the challenge to the intimate life of the
couple.
Artificial methods of contraception: spermicide
For women who decide to use artificial means of contra-
ception, there are various options, which include spermi-
cide, barrier methods, intrauterine device and hormonal
preparations. Spermicide, usually containing varying con-
centrations of nonoxynol-9, destroys sperm on contact.
Higher concentrations of spermicide, such as in vaginal
suppository form, are 90% effective in preventing preg-
nancy as compared to the effectiveness of spermicide gels
and films (ranging from 78%–88% in the six month study
period) [31]. This method is not deleterious to the breast-
feeding mother-infant dyad, as it does not enter the milkInternational Breastfeeding Journal 2007, 2:1 http://www.internationalbreastfeedingjournal.com/content/2/1/1
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nor affect production. Most halakhic authorities permit
use of spermicide when contraception is indicated since
its use alone does not impede vaginal intercourse [32].
Additionally, halakhic authorities consider it a temporary
method of contraception with a method of action that is
activated only after emission of sperm into the vaginal
canal [15]. Use of spermicide does not usually pose bleed-
ing risks to women, although women who are sensitive to
spermicide may experience vaginal irritation and bleed-
ing. This bleeding, of vaginal and not of uterine origin,
may cause concern to the halakha observant woman, as it
may be confused with uterine bleeding. This problem can
often be addressed by the use of a different brand or for-
mulation of spermicide, or by considering a different con-
traceptive method.
Artificial methods of contraception: barrier methods
Barrier methods such as the diaphragm, cervical cap, and
contraceptive sponge are more effective with use of sper-
micides and may be more effective than spermicide use
alone. These methods are not deleterious to the breast-
feeding mother-infant dyad as they do not have a systemic
effect on the mother and therefore do not affect the qual-
ity or quantity of milk. However, they are often consid-
ered a less preferred option for the halakha observant
woman [21]. This is due to the fact that some halakhic
authorities consider the diaphragm analogous to the Tal-
mudic moch whose use is limited. Additionally, the dia-
phragm impedes the progress of the sperm to the cervix,
although it does not prevent the deposit of the sperm into
the vaginal canal. Nevertheless, some halakhic authorities
permit the use of the diaphragm or cervical cap since
proper insertion is deep enough for the husband to be
unaware of its presence and intercourse continues to be
performed in a natural manner. Compared to the dia-
phragm and cervical cap, contraceptive sponges are less
halakhically desirable since they occupy a large area of the
vagina, potentially impeding normal intercourse; how-
ever there are halakhic authorities who permit their use.
Artificial methods of contraception: intrauterine device
The intrauterine device (IUD) is a reversible contraceptive
method whose mechanism of action is not completely
clear and does not disrupt breastfeeding or milk produc-
tion. Likewise, the IUD containing the progestin lev-
onorgestrel (e.g. Mirena) should not disrupt breastfeeding
or milk production [33]. Since the IUD is reversible and
does not interfere with sexual relations, it should be a
halakhically accepted form of contraception. However,
there is some debate. Some rabbinic authorities permit
use of the IUD based on the understanding that its mech-
anism of action is interference with implantation, while
others consider the IUD to be a form of abortion and pro-
hibit its use [34]. Furthermore, there are health issues that
have raised concern with the IUD, such as the associated
risk of pelvic inflammatory disease [35], while recent
research has minimized some concerns such as tubal
infertility [36]. Since preserving health is of concern in
Jewish law and the health risks have been demonstrated,
some halakhic authorities do not support use of this
method. Another potential problem of the IUD for the
halakha observant woman is the increased risk of bleed-
ing and staining for months following insertion and
increased risk of extended niddah status.
Artificial methods of contraception: hormonal 
preparations
There are two categories of contraceptive preparations.
One category is progesterone-only, available in oral ("the
mini pill"), injectable (e.g. Depo-Provera), and subcuta-
neous implant (e.g. Norplant) forms. The other contains
combinations of estrogen and progesterone available as a
pill, patch and vaginal ring. Hormonal methods which
include estrogen are contraindicated in women with med-
ical conditions such as liver disease, elevated blood pres-
sure and clotting problems.
Hormonal contraception is often discouraged for breast-
feeding women. The two concerns expressed are the trans-
fer of hormones to the infant via the breast milk and the
effect on milk quality and/or quantity. The transfer of hor-
mones via human milk is minimal and no long-term
adverse effects on child growth and development have
been reported. The American Academy of Pediatrics con-
siders hormonal contraceptives to be compatible with
breastfeeding [37]. Regarding the effect on milk, proges-
terone-only methods do not diminish the volume or com-
position of breast milk [38], thus they are the preferred
method of hormonal contraception for the lactating
woman. Out of concern for protecting the normal drop in
progesterone following delivery of the placenta, necessary
for successful lactation, progesterone-only contraception
should not be started prior to three weeks postpartum
[38]. On the other hand, there is a risk of decreased milk
volume with use of combined hormonal contraceptives
[39]. For the breastfeeding woman, use of combined hor-
monal contraceptive should be discouraged or at least
delayed until six months postpartum so as not to disturb
exclusive breastfeeding. If a breastfeeding woman should
decide to use combined hormonal preparations within
the first six months, she should be advised to wait until
breast milk production is well established, be given antic-
ipatory guidance regarding methods of maintaining and
increasing milk supply, and started on the lowest possible
dosage of estrogen.
According to most halakhic opinions, hormonal regula-
tion is the first choice of medical contraception; it is tem-
porary and provides no physical barrier to intercourse.
Some authorities, however, are concerned about the rareInternational Breastfeeding Journal 2007, 2:1 http://www.internationalbreastfeedingjournal.com/content/2/1/1
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but serious side-effects associated with the estrogen con-
taining methods including increased risk of thromboem-
bolic events. Unpredictable vaginal bleeding is a common
complaint with progesterone-only methods [40], an issue
of marked concern to the halakha observant woman. The
problem can be compounded with the injectable form
since the drug remains in the body for an extended period
following injection and the symptoms may take months
to resolve. Similarly, the subcutaneous implants require
surgical removal for resolution of the undesired symp-
toms. With the combination methods as well there is an
increased risk of extended niddah  status since break-
through bleeding can be a concern, especially in the first
few months [41,42].
Conclusion
Breastfeeding women should choose methods that are not
deleterious to the success of lactation or to the infant's
health. The halakha observant woman is faced with a
challenge regarding contraceptive use during lactation.
The order of preference for the halakha observant breast-
feeding woman may vary from the medical order of pref-
erence. Following halakhic permission to use artificial
contraception, halakhic preference includes methods that
are safe, effective, do not interfere with normal sexual rela-
tions, and have minimal side effects, especially intermen-
strual bleeding or staining. It is common for the halakhic
authority to advise hormonal contraception, assuming no
contraindications. It is important for a woman who had
experienced side effects with this method, especially
bleeding or staining, to re-consult with her halakhic
authority.
When hormonal preparations are chosen for contracep-
tion during lactation, the preference is a progesterone-
only method since preparations containing estrogens may
threaten breastfeeding success. Switching contraceptive
methods may be recommended if intermenstrual bleed-
ing or staining is experienced, rendering the woman a nid-
dah. Subsequently, or alternatively, an IUD may be
recommended. This can also pose problems of bleeding
and staining placing stress on intimacy. Female barrier
methods and spermicides are safe for the breastfeeding
mother-infant dyad and do not pose complications such
as bleeding and staining, although they are not a simple
issue for the halakha observant woman.
Knowledge and sensitivity of the many factors that may
influence the choice of contraceptive means is necessary
for providing each individual woman with appropriate
advice regarding contraception during lactation. Dual
consultation with the health care provider and halakhic
authority should help the lactating halakha observant
woman choose a contraceptive method that preserves the
important breastfeeding relationship with her infant.
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